The Oncology Institute, Inc. TOI Finite Lived Intangible Assets - Gross
Finite Lived Intangible Assets - Gross at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s finite lived intangible assets - gross.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s finite lived intangible assets - gross?
- The Oncology Institute, Inc. (TOI) reported finite lived intangible assets - gross of $29.77M in Q1 2026.
- How has The Oncology Institute, Inc.'s finite lived intangible assets - gross changed year-over-year?
- The Oncology Institute, Inc.'s finite lived intangible assets - gross decreased by 7.1% year-over-year, from $32.03M to $29.77M.
- What is the long-term trend for The Oncology Institute, Inc.'s finite lived intangible assets - gross?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s finite lived intangible assets - gross has grown at a 3.0% compound annual growth rate (CAGR), from $26.48M to $29.77M.
- What does finite lived intangible assets - gross mean?
- This metric tracks the total historical cost of intangible assets that have a defined useful life, such as patents, software licenses, or customer relationships. It excludes assets with indefinite lives like certain trademarks or goodwill. It is a key indicator of the company's investment in intellectual property and intangible competitive advantages.